Giving the fact that withdrawal of anti-VEGF therapy induced hyper-leakiness and loss of VE-cadherin in hepatic capillaries, we hypothesized that off-drug would increase tumour cell extravasation in liver. The gene discussed is CDH5; the disease is neoplasm.